ChartWater™ and Calgon Carbon Announce Referral Agreement
ChartWater’s AdEdge Center of Excellence and Calgon Carbon signed an agreement to partner in offering drinking water treatment systems to under-resourced, rural communities.
Pittsburgh, Pennsylvania, June 09, 2022 (GLOBE NEWSWIRE) -- ChartWater™ a division of Chart Industries, Inc. (“Chart”) (NYSE: GTLS), and Calgon Carbon Corporation (“Calgon Carbon”), a wholly owned subsidiary of Kuraray Co., Ltd. (TYO: 3405) (“Kuraray”), today formally announced an agreement signed in 2021 to jointly offer drinking water systems, using granular activated carbon, to under-resourced rural areas.
The terms of the Agreement allow Calgon Carbon to refer all communities in the United States requiring treatment of up to approximately 175 gallons per minute to ChartWater’s AdEdge Water Technologies (AdEdge ), who will source all related GAC from Calgon Carbon. While both companies will continue to provide water treatment solutions for all flow rates, the Agreement enables the Companies to combine their capabilities for solutions that will cost-effectively provide safe drinking water to communities.
According to the U.S. EPA’s Safe Drinking Water Act, there are over 140,000 small drinking water systems in the United States. Many of these systems face challenges in meeting ever-changing and stringent regulations around drinking water contamination, making it difficult to provide consistently safe drinking water to customers. The new Agreement offers these small systems access to AdEdge’s variety of equipment offerings as well as Calgon Carbon’s premium product line, FILTRASORB® GAC.
“We are excited to partner with Calgon Carbon to combine their decades of GAC experience with our experience providing complete, packaged treatment systems to municipalities around the United States,” said Chris Milligan, President of ChartWater™. “ChartWater’s AdEdge Center of Excellence provides solutions for municipal and industrial customers of all sizes. This relationship with Calgon Carbon will specifically strengthen our ability to serve smaller utilities with a world-class GAC solution for the removal of PFAS, TOC, disinfection byproducts, and any other contaminants that can be addressed with GAC.”
Since creating the first activated carbon products from bituminous coal in the 1940s, Calgon Carbon has been a pioneer in developing high performing granular activated carbon products for water purification.
“Calgon Carbon has provided GAC to hundreds of water suppliers for over 40 years, and we are enthusiastic about this Agreement,” said Nora Stockhausen, VP of the Drinking Water Solutions and Innovative Carbon Technologies business unit. “This collaboration allows our FILTRASORB® GAC to be more accessible to smaller utilities through AdEdge’s reach in this market and we’re proud to work together to provide clean, safe drinking water to more Americans.”
About Chart Industries, Inc.
Chart Industries, Inc. is a leading independent global manufacturer of highly engineered equipment servicing multiple applications in the Energy and Industrial Gas markets. Our unique product portfolio is used in every phase of the liquid gas supply chain, including upfront engineering, service and repair. Being at the forefront of the clean energy transition, Chart is a leading provider of technology, equipment and services related to liquefied natural gas, hydrogen, biogas and CO2 Capture amongst other applications. We are committed to excellence in environmental, social and corporate governance (ESG) issues both for our company as well as our customers. With over 25 global locations from the United States to Asia, Australia, India, Europe and South America, we maintain accountability and transparency to our team members, suppliers, customers and communities. To learn more, visit www.chartindustries.com.
ChartWater™, a division of Chart Industries, is a global manufacturer and service provider of engineered solutions for municipal water treatment and industrial process applications. Its portfolio of proven products, processes, and engineering expertise provides customers with single-point responsibility for complete solutions that enable water professionals to achieve their objectives with the lowest combination of risk and costs while driving enhanced outcomes for people, communities, and the planet. For more information, visit www.chartindustries.com/products/water-treatment
About AdEdge Water Technologies
Founded in 2002 and headquartered just north of Atlanta, Georgia, USA, AdEdge Water Technologies, LLC is a leading provider of advanced water treatment technologies and systems serving municipal, residential and industrial applications nationally and overseas for flow rates up to 15 MGD. AdEdge manufacturers fully integrated and custom water treatment systems to remove over twenty different contaminants from water, including arsenic, iron, manganese, fluoride, PFAS, TOC, and radionuclides. AdEdge also offers an ultra-high recovery reverse osmosis membrane solution for removal of TDS and multiple contaminants, using ROTEC’s Flow Reversal Reverse Osmosis. AdEdge was acquired by Chart Industries in August of 2021 as a ChartWater Center of Excellence. For more information, visit www.adedgetech.com.
About Calgon Carbon
Calgon Carbon, a wholly-owned subsidiary of Kuraray Co., Ltd. (TYO: 3405) (Kuraray), is a global leader in the manufacture and/or distribution of innovative coal-, wood- and coconut-based activated carbon products – in granular, powdered, pelletized and cloth form – to meet the most challenging purification demands of customers throughout the world. Calgon Carbon provides purification solutions for more than 700 distinct applications, including drinking water, wastewater, pollution abatement, and a variety of industrial and commercial manufacturing processes. Headquartered in Pittsburgh, Pennsylvania, Calgon Carbon employs approximately 1640 people and operates 20 manufacturing, reactivation, innovation and equipment fabrication facilities in the U.S., Asia, and in Europe, where Calgon Carbon is known as Chemviron. Calgon Carbon was acquired by Kuraray in March of 2018. With complementary products and services, the combined organization will continue to focus on providing the highest quality and most innovative activated carbon and filtration media products, equipment, and services to meetTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Basilea reports progress on the implementation of its strategy to focus on anti-infectives27.6.2022 07:15:00 CEST | Press release
ERADICATE phase 3 study exploring ceftobiprole for the treatment of patients with Staphylococcus aureus bacteremia (SAB) expected to report results shortlySeparate transactions for TTK/PLK1 inhibitor (BAL0891) and preclinical oncology projects expected to be concluded in H2 2022 No expansion of ongoing lisavanbulin clinical studies; exploring partnering opportunitiesDerazantinib rights to be transferred back to Merck & Co. by the end of 2022No material expenses related to oncology activities beyond 2022 and sustainable profitability expected in 2023Strategy implementation on track Ad hoc announcement pursuant to Art. 53 LR Basel/Allschwil, Switzerland, June 27, 2022 Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company, announced today an update on the progress made in the implementation of its strategic focus on anti-infectives. David Veitch, Chief Executive Officer, stated: “We have made significant progress in the implementation of our new strategy. Wit
Report – ERYTECH’s Combined Shareholders’ Meeting On June 24, 202224.6.2022 22:05:00 CEST | Press release
REPORT –ERYTECH’S COMBINED SHAREHOLDERS’ MEETING ON JUNE 24, 2022 Cambridge, MA (U.S.) and Lyon (France), June24, 2022 – ERYTECH Pharma (Nasdaq& Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announcedthat its Annual General Meeting was held on Friday, June 24, 2022. At the meeting, all resolutions for which the Board of Directors recommended a vote in favor were adopted, including: Approval of the annual financial statements and consolidated financial statements for the year ended December 31, 2021;Allocation of the financial year's results;Approval of the statutory auditors’ special report on regulated agreements and commitments with related parties;Approval of the elements of total compensation and benefits paid or allocated for the year ended December 31, 2021, to Gil BEYEN, Chief Executive Officer and Jean-Paul KRESS, Chairman of the Board;Approval of the compens
Cleantech Building Materials: Results of Annual General Meeting24.6.2022 14:54:27 CEST | Press release
24 June 2022 CLEANTECH BUILDING MATERIALS PLC, NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN TICKER: CBM ISIN: GBOOBD1LVD21 CLEANTECH BUILDING MATERIALS PLC Results of Annual General Meeting The Annual General Meeting (“AGM”) of Cleantech Building Materials plc (“CBM” or the “Company”) was held in London earlier today, 24 June 2022. Details of the resolutions to be considered at the AGM were published in the Notice of AGM which was posted to Shareholders on 1 June 2022 and is available on the Company’s website: www.cbm-plc.com. All resolutions as set out in the Notice of AGM were duly passed without discussion. In particular, the following resolutions were passed at the AGM. The AGM resolved to authorise the directors of the Company to allot shares and grant rights to subscribe for, or convert any security, into shares. The directors of the Company sought authority for the purposes of section 551 of the Companies Act to exercise all the powers of the Company to allot shares and grant ri
Novartis receives positive CHMP opinion for Scemblix®, a novel treatment for adult patients with chronic myeloid leukemia24.6.2022 13:13:19 CEST | Press release
With unique STAMP mechanism of action, Scemblix could provide a new option for patients in Europe with chronic myeloid leukemia (CML) who have suffered intolerance or inadequate response with at least two prior tyrosine kinase inhibitor treatments1 Positive opinion based on data from pivotal Phase III ASCEMBL trial, showing a near doubling in major molecular response rate for patients treated with Scemblix® (asciminib) vs. Bosulif®* (bosutinib) (25.5% vs. 13.2%) and more than three times lower discontinuation rate due to adverse reactions (5.8% vs 21.1%) at 24 weeks1 CHMP recommendation comes after the approval of Scemblix by the US FDA and other countries’ regulatory authorities, potentially broadening access for more patients to Novartis transformative therapies in CML Basel, June 24, 2022 — Novartis today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting marketing au
Clariant’s shareholders approve all agenda items24.6.2022 11:30:00 CEST | Press release
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Integrated Report and Group Consolidated Financial Statements for fiscal year 2021 approvedGünter von Au reelected as Chairman of the Board of DirectorsThree new candidates join the Board of Directors: Ahmed Mohamed Alumar, Roberto César Gualdoni, Naveena ShastriConfirmed distribution of CHF 0.40 per shareKPMG confirmed as statutory auditor from 2022 MUTTENZ, JUNE 24, 2022 Clariant, a focused, sustainable, and innovative specialty chemical company, today held its 27th Annual General Meeting (AGM) where the shareholders approved all agenda items and resolutions as proposed by the Board of Directors. The AGM was held virtually, where shareholders were able to exercise their rights exclusively via the independent proxy. Overall, 698'945'298 shares or around 70.19 % of the share capital of Clariant were represented. Günter von Au was reelected as Chairman of the Board of Directors. Additionally, three new members were voted to join by a large majo